Enterprise Value
53.22M
Cash
7.622M
Avg Qtr Burn
-21.47M
Short % of Float
9.26%
Insider Ownership
0.05%
Institutional Own.
76.77%
Qtr Updated
06/30/23
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
EDP1815 Details Atopic dermatitis | Failed Discontinued | |
EDP1815 Details COVID-19 | Failed Discontinued | |
EDP1815 Details Psoriasis | Failed Discontinued | |
EDP1867 Details Atopic dermatitis | Failed Discontinued | |
EDP2939 Details Psoriasis | Failed Discontinued |